{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:25:35Z","timestamp":1764019535637,"version":"3.32.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1136\/ard.2004.030262","type":"journal-article","created":{"date-parts":[[2005,7,13]],"date-time":"2005-07-13T21:12:39Z","timestamp":1121289159000},"page":"1224-1226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Blockade of tumour necrosis factor \u03b1 significantly alters the serum level of IgG- and IgA-rheumatoid factor in patients with rheumatoid arthritis"],"prefix":"10.1016","volume":"64","author":[{"given":"B","family":"Yazdani-Biuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Stadlmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Mulabecirovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Brezinschek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Tilz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"Demel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Brickmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W B","family":"Graninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H-P","family":"Brezinschek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2004.030262_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(81)91107-7","article-title":"Rheumatoid arthritis: a disease of T-lymphocyte\/macrophage immunoregulation","volume":"ii","author":"Janossy","year":"1981","journal-title":"Lancet"},{"key":"10.1136\/ard.2004.030262_bib2","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra032906","article-title":"New drugs for rheumatoid arthritis","volume":"350","author":"Olsen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2004.030262_bib3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/ard.62.5.427","article-title":"Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis","volume":"62","author":"Vencovsky","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.030262_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0022-1759(84)90061-9","article-title":"Use of monoclonal antibodies and F(ab\u2032)2 enzyme conjugates in ELISA for IgM, IgA and IgG rheumatoid factors","volume":"71","author":"Teitsson","year":"1984","journal-title":"J Immunol Methods"},{"key":"10.1136\/ard.2004.030262_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/clim.2001.5183","article-title":"Immune function in patients with rheumatoid arthritis treated with etanercept","volume":"103","author":"Moreland","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1136\/ard.2004.030262_bib6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(02)07714-0","article-title":"Drug-induced systemic lupus erythematosus associated with etanercept therapy","volume":"359","author":"Shakoor","year":"2002","journal-title":"Lancet"},{"key":"10.1136\/ard.2004.030262_bib7","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/1529-0131(200011)43:11<2383::AID-ANR2>3.0.CO;2-D","article-title":"Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials","volume":"43","author":"Charles","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030262_bib8","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0016-5085(99)70294-5","article-title":"The relationship between infliximab treatment and lymphoma in Crohn's disease","volume":"117","author":"Bickston","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1136\/ard.2004.030262_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00002281-200405000-00014","article-title":"Rheumatoid arthritis and malignant lymphomas","volume":"16","author":"Baecklund","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.2004.030262_bib10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2567.1999.00772.x","article-title":"Do self-perpetuating B lymphocytes drive human autoimmune disease?","volume":"97","author":"Edwards","year":"1999","journal-title":"Immunology"},{"key":"10.1136\/ard.2004.030262_bib11","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1084\/jem.185.12.2111","article-title":"Lymphotoxin-alpha (LTalpha) supports development of splenic follicular structure that is required for IgG responses","volume":"185","author":"Fu","year":"1997","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2004.030262_bib12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/ard.2004.024182","article-title":"Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF-alpha therapy","volume":"64","author":"Eriksson","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.030262_bib13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF00207484","article-title":"Cell-type specific response of peripheral blood lymphocytes to methotrexate in the treatment of rheumatoid arthritis","volume":"72","author":"Wascher","year":"1994","journal-title":"Clin Investig"},{"key":"10.1136\/ard.2004.030262_bib14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","article-title":"Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial","volume":"363","author":"Klareskog","year":"2004","journal-title":"Lancet"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724429087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724429087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2004.030262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T05:21:14Z","timestamp":1736140874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724429087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0003496724429087"],"URL":"https:\/\/doi.org\/10.1136\/ard.2004.030262","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blockade of tumour necrosis factor \u03b1 significantly alters the serum level of IgG- and IgA-rheumatoid factor in patients with rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2004.030262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Copyright 2005 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}